170 related articles for article (PubMed ID: 37114250)
1. Evaluation of the current MicroRNAs expression levels as potential biomarkers in Oral Squamous Cell Carcinoma.
Tahmasebi E; Kaboudanian Ardestani A; Madihi N; Abbasiparashkouh Z; Abbasi Maleki S; Yazdanian M; Khafaei M; Movafagh A; Tavallaie M
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):193-198. PubMed ID: 37114250
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
3. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
5. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
6. THE STUDY OF PROGNOSTIC VALUE OF microRNAs (miR-10b AND -155) AND CDKN2A/P16INK4A IN ORAL SQUAMOUS CELL CARCINOMA.
Kravets О; Burtyn O; Borikun T; Rossylna O
Exp Oncol; 2023 Oct; 45(2):187-194. PubMed ID: 37824773
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
8. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
10. Exploring miR-155-5p and miR-1246 as Diagnostic and Prognostic Markers in Oral Squamous cell carcinoma.
Maheswari R; Urs AB; Kumar P; Koner BC; Guru SA; Rawat G
Mol Biol Rep; 2024 Feb; 51(1):341. PubMed ID: 38400867
[TBL] [Abstract][Full Text] [Related]
11. Assessment of MicroRNA-15a and MicroRNA-16-1 Salivary Level in Oral Squamous Cell Carcinoma Patients.
Koopaie M; Manifar S; Lahiji SS
Microrna; 2021; 10(1):74-79. PubMed ID: 33970852
[TBL] [Abstract][Full Text] [Related]
12. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".
Tarrad NAF; Hassan S; Shaker OG; AbdelKawy M
BMC Oral Health; 2023 Dec; 23(1):994. PubMed ID: 38087258
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the role of microRNAs alterations in oral squamous cell carcinoma.
Aali M; Mesgarzadeh AH; Najjary S; Abdolahi HM; Kojabad AB; Baradaran B
Gene; 2020 Oct; 757():144936. PubMed ID: 32640301
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of salivary miR-3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus.
Farshbaf A; Mohajertehran F; Aghaee-Bakhtiari SH; Ayatollahi H; Douzandeh K; Pakfetrat A; Mohtasham N
Clin Exp Dent Res; 2024 Apr; 10(2):e877. PubMed ID: 38481355
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
16. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
[TBL] [Abstract][Full Text] [Related]
17. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
[TBL] [Abstract][Full Text] [Related]
18. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma.
Rajan C; Roshan VGD; Khan I; Manasa VG; Himal I; Kattoor J; Thomas S; Kondaiah P; Kannan S
Sci Rep; 2021 Mar; 11(1):7298. PubMed ID: 33790326
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
20. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.
Mazumder S; Basu B; Ray JG; Chatterjee R
Arch Oral Biol; 2023 Mar; 147():105627. PubMed ID: 36657275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
